nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC2—esophageal cancer	0.204	0.424	CbGaD
Nifedipine—CYP2A6—esophageal cancer	0.202	0.419	CbGaD
Nifedipine—ABCB1—esophageal cancer	0.075	0.156	CbGaD
Nifedipine—ABCC3—Cisplatin—esophageal cancer	0.0727	0.255	CbGbCtD
Nifedipine—ABCC3—Methotrexate—esophageal cancer	0.0472	0.166	CbGbCtD
Nifedipine—ABCC2—Carboplatin—esophageal cancer	0.0387	0.136	CbGbCtD
Nifedipine—ABCC2—Cisplatin—esophageal cancer	0.033	0.116	CbGbCtD
Nifedipine—CYP2C9—Capecitabine—esophageal cancer	0.022	0.0773	CbGbCtD
Nifedipine—ABCC2—Methotrexate—esophageal cancer	0.0214	0.0753	CbGbCtD
Nifedipine—CYP2B6—Cisplatin—esophageal cancer	0.021	0.0737	CbGbCtD
Nifedipine—CYP2C9—Cisplatin—esophageal cancer	0.0111	0.0389	CbGbCtD
Nifedipine—ABCB1—Cisplatin—esophageal cancer	0.0108	0.0378	CbGbCtD
Nifedipine—ABCB1—Methotrexate—esophageal cancer	0.00699	0.0245	CbGbCtD
Nifedipine—CALM2—exocrine gland—esophageal cancer	0.0011	0.0425	CbGeAlD
Nifedipine—CALM1—exocrine gland—esophageal cancer	0.00109	0.0423	CbGeAlD
Nifedipine—CACNA1H—smooth muscle tissue—esophageal cancer	0.000917	0.0355	CbGeAlD
Nifedipine—Amlodipine—CA1—esophageal cancer	0.00075	0.31	CrCbGaD
Nifedipine—CALM2—neck—esophageal cancer	0.000701	0.0272	CbGeAlD
Nifedipine—CACNA1C—smooth muscle tissue—esophageal cancer	0.000699	0.0271	CbGeAlD
Nifedipine—CALM1—neck—esophageal cancer	0.000698	0.0271	CbGeAlD
Nifedipine—CACNB2—digestive system—esophageal cancer	0.000684	0.0265	CbGeAlD
Nifedipine—CALM3—bronchus—esophageal cancer	0.000598	0.0232	CbGeAlD
Nifedipine—CALM3—smooth muscle tissue—esophageal cancer	0.000585	0.0227	CbGeAlD
Nifedipine—CACNB2—lung—esophageal cancer	0.000571	0.0221	CbGeAlD
Nifedipine—CACNA1C—digestive system—esophageal cancer	0.000552	0.0214	CbGeAlD
Nifedipine—CALM3—trachea—esophageal cancer	0.000537	0.0208	CbGeAlD
Nifedipine—CACNA2D1—lung—esophageal cancer	0.000536	0.0208	CbGeAlD
Nifedipine—ABCC3—digestive system—esophageal cancer	0.000502	0.0195	CbGeAlD
Nifedipine—CACNA1D—lung—esophageal cancer	0.000499	0.0193	CbGeAlD
Nifedipine—CALM2—epithelium—esophageal cancer	0.000477	0.0185	CbGeAlD
Nifedipine—CALM1—epithelium—esophageal cancer	0.000475	0.0184	CbGeAlD
Nifedipine—Nilvadipine—CYP2A6—esophageal cancer	0.000473	0.195	CrCbGaD
Nifedipine—CALM2—bronchus—esophageal cancer	0.00047	0.0182	CbGeAlD
Nifedipine—CALM1—bronchus—esophageal cancer	0.000468	0.0181	CbGeAlD
Nifedipine—CACNA1C—lung—esophageal cancer	0.000461	0.0179	CbGeAlD
Nifedipine—CALM2—smooth muscle tissue—esophageal cancer	0.00046	0.0178	CbGeAlD
Nifedipine—CALM1—smooth muscle tissue—esophageal cancer	0.000458	0.0177	CbGeAlD
Nifedipine—CYP2A6—lung—esophageal cancer	0.000448	0.0173	CbGeAlD
Nifedipine—CALM2—trachea—esophageal cancer	0.000422	0.0164	CbGeAlD
Nifedipine—CALM1—trachea—esophageal cancer	0.00042	0.0163	CbGeAlD
Nifedipine—ABCC3—lung—esophageal cancer	0.000419	0.0162	CbGeAlD
Nifedipine—CACNA1H—lymph node—esophageal cancer	0.000414	0.016	CbGeAlD
Nifedipine—Amlodipine—CYP2A6—esophageal cancer	0.000407	0.168	CrCbGaD
Nifedipine—ABCC2—digestive system—esophageal cancer	0.000401	0.0155	CbGeAlD
Nifedipine—CACNB2—lymph node—esophageal cancer	0.000391	0.0151	CbGeAlD
Nifedipine—CALM3—lung—esophageal cancer	0.000386	0.015	CbGeAlD
Nifedipine—CACNA2D1—lymph node—esophageal cancer	0.000367	0.0142	CbGeAlD
Nifedipine—CYP1A1—epithelium—esophageal cancer	0.000365	0.0141	CbGeAlD
Nifedipine—CALM2—digestive system—esophageal cancer	0.000363	0.0141	CbGeAlD
Nifedipine—CALM1—digestive system—esophageal cancer	0.000361	0.014	CbGeAlD
Nifedipine—CYP1A1—bronchus—esophageal cancer	0.000359	0.0139	CbGeAlD
Nifedipine—CYP2B6—bronchus—esophageal cancer	0.000349	0.0135	CbGeAlD
Nifedipine—CACNA1D—lymph node—esophageal cancer	0.000341	0.0132	CbGeAlD
Nifedipine—CYP1A1—trachea—esophageal cancer	0.000323	0.0125	CbGeAlD
Nifedipine—CACNA1C—lymph node—esophageal cancer	0.000315	0.0122	CbGeAlD
Nifedipine—CALM2—lung—esophageal cancer	0.000303	0.0117	CbGeAlD
Nifedipine—CALM1—lung—esophageal cancer	0.000302	0.0117	CbGeAlD
Nifedipine—ABCC3—lymph node—esophageal cancer	0.000287	0.0111	CbGeAlD
Nifedipine—CYP1A2—digestive system—esophageal cancer	0.000282	0.0109	CbGeAlD
Nifedipine—CYP1A1—digestive system—esophageal cancer	0.000278	0.0108	CbGeAlD
Nifedipine—CYP3A5—digestive system—esophageal cancer	0.000272	0.0105	CbGeAlD
Nifedipine—CYP2B6—digestive system—esophageal cancer	0.00027	0.0105	CbGeAlD
Nifedipine—CYP2C9—digestive system—esophageal cancer	0.000267	0.0104	CbGeAlD
Nifedipine—CALM3—lymph node—esophageal cancer	0.000264	0.0102	CbGeAlD
Nifedipine—CYP2E1—digestive system—esophageal cancer	0.000253	0.00981	CbGeAlD
Nifedipine—CYP1A2—lung—esophageal cancer	0.000235	0.00911	CbGeAlD
Nifedipine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000233	0.00297	CcSEcCtD
Nifedipine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000232	0.00296	CcSEcCtD
Nifedipine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000232	0.00296	CcSEcCtD
Nifedipine—CYP1A1—lung—esophageal cancer	0.000232	0.00899	CbGeAlD
Nifedipine—Urethral disorder—Cisplatin—esophageal cancer	0.000231	0.00295	CcSEcCtD
Nifedipine—Gynaecomastia—Methotrexate—esophageal cancer	0.000231	0.00294	CcSEcCtD
Nifedipine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00023	0.00293	CcSEcCtD
Nifedipine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00023	0.00293	CcSEcCtD
Nifedipine—ABCC2—lymph node—esophageal cancer	0.000229	0.00888	CbGeAlD
Nifedipine—Visual impairment—Cisplatin—esophageal cancer	0.000228	0.0029	CcSEcCtD
Nifedipine—Breast disorder—Capecitabine—esophageal cancer	0.000227	0.0029	CcSEcCtD
Nifedipine—CYP3A5—lung—esophageal cancer	0.000227	0.00879	CbGeAlD
Nifedipine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000227	0.00289	CcSEcCtD
Nifedipine—CYP2B6—lung—esophageal cancer	0.000225	0.00873	CbGeAlD
Nifedipine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000222	0.00283	CcSEcCtD
Nifedipine—Muscular weakness—Capecitabine—esophageal cancer	0.000222	0.00283	CcSEcCtD
Nifedipine—Eye disorder—Cisplatin—esophageal cancer	0.000221	0.00281	CcSEcCtD
Nifedipine—Tinnitus—Cisplatin—esophageal cancer	0.00022	0.00281	CcSEcCtD
Nifedipine—Lymphadenopathy—Methotrexate—esophageal cancer	0.00022	0.0028	CcSEcCtD
Nifedipine—Flushing—Cisplatin—esophageal cancer	0.000219	0.00279	CcSEcCtD
Nifedipine—Cardiac disorder—Cisplatin—esophageal cancer	0.000219	0.00279	CcSEcCtD
Nifedipine—Abdominal distension—Capecitabine—esophageal cancer	0.000219	0.00279	CcSEcCtD
Nifedipine—Dysphagia—Capecitabine—esophageal cancer	0.000217	0.00277	CcSEcCtD
Nifedipine—Bronchospasm—Capecitabine—esophageal cancer	0.000214	0.00273	CcSEcCtD
Nifedipine—Polyuria—Methotrexate—esophageal cancer	0.000213	0.00272	CcSEcCtD
Nifedipine—Immune system disorder—Cisplatin—esophageal cancer	0.000213	0.00272	CcSEcCtD
Nifedipine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000213	0.00271	CcSEcCtD
Nifedipine—Sweating increased—Capecitabine—esophageal cancer	0.000212	0.0027	CcSEcCtD
Nifedipine—Angina pectoris—Capecitabine—esophageal cancer	0.000212	0.0027	CcSEcCtD
Nifedipine—CYP2E1—lung—esophageal cancer	0.000212	0.0082	CbGeAlD
Nifedipine—Arrhythmia—Cisplatin—esophageal cancer	0.000211	0.00269	CcSEcCtD
Nifedipine—Alopecia—Cisplatin—esophageal cancer	0.000209	0.00266	CcSEcCtD
Nifedipine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000208	0.00266	CcSEcCtD
Nifedipine—CALM2—lymph node—esophageal cancer	0.000207	0.00804	CbGeAlD
Nifedipine—CALM1—lymph node—esophageal cancer	0.000206	0.008	CbGeAlD
Nifedipine—Erythema—Cisplatin—esophageal cancer	0.000206	0.00262	CcSEcCtD
Nifedipine—Malnutrition—Cisplatin—esophageal cancer	0.000206	0.00262	CcSEcCtD
Nifedipine—CYP3A4—digestive system—esophageal cancer	0.000204	0.0079	CbGeAlD
Nifedipine—Dysuria—Capecitabine—esophageal cancer	0.000203	0.00259	CcSEcCtD
Nifedipine—Flatulence—Cisplatin—esophageal cancer	0.000203	0.00258	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000202	0.00258	CcSEcCtD
Nifedipine—CYP2D6—digestive system—esophageal cancer	0.000201	0.00777	CbGeAlD
Nifedipine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000198	0.00253	CcSEcCtD
Nifedipine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000198	0.00253	CcSEcCtD
Nifedipine—Weight increased—Capecitabine—esophageal cancer	0.000198	0.00252	CcSEcCtD
Nifedipine—Visual disturbance—Methotrexate—esophageal cancer	0.000198	0.00252	CcSEcCtD
Nifedipine—Muscle spasms—Cisplatin—esophageal cancer	0.000198	0.00252	CcSEcCtD
Nifedipine—Weight decreased—Capecitabine—esophageal cancer	0.000197	0.00251	CcSEcCtD
Nifedipine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000196	0.0025	CcSEcCtD
Nifedipine—Vision blurred—Cisplatin—esophageal cancer	0.000194	0.00247	CcSEcCtD
Nifedipine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000193	0.00247	CcSEcCtD
Nifedipine—Tremor—Cisplatin—esophageal cancer	0.000193	0.00246	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000192	0.00245	CcSEcCtD
Nifedipine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000191	0.00243	CcSEcCtD
Nifedipine—Anaemia—Cisplatin—esophageal cancer	0.00019	0.00242	CcSEcCtD
Nifedipine—ABCB1—epithelium—esophageal cancer	0.00019	0.00735	CbGeAlD
Nifedipine—Jaundice—Capecitabine—esophageal cancer	0.000189	0.00241	CcSEcCtD
Nifedipine—Conjunctivitis—Capecitabine—esophageal cancer	0.000188	0.0024	CcSEcCtD
Nifedipine—Nisoldipine—ABCB1—esophageal cancer	0.000188	0.0778	CrCbGaD
Nifedipine—Osteoarthritis—Methotrexate—esophageal cancer	0.000187	0.00239	CcSEcCtD
Nifedipine—Malaise—Cisplatin—esophageal cancer	0.000185	0.00236	CcSEcCtD
Nifedipine—Haematuria—Capecitabine—esophageal cancer	0.000185	0.00236	CcSEcCtD
Nifedipine—Leukopenia—Cisplatin—esophageal cancer	0.000184	0.00235	CcSEcCtD
Nifedipine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000183	0.00234	CcSEcCtD
Nifedipine—Epistaxis—Capecitabine—esophageal cancer	0.000183	0.00233	CcSEcCtD
Nifedipine—Agranulocytosis—Capecitabine—esophageal cancer	0.000181	0.00231	CcSEcCtD
Nifedipine—Mood swings—Methotrexate—esophageal cancer	0.000177	0.00226	CcSEcCtD
Nifedipine—Bradycardia—Capecitabine—esophageal cancer	0.000177	0.00226	CcSEcCtD
Nifedipine—Ataxia—Methotrexate—esophageal cancer	0.000176	0.00225	CcSEcCtD
Nifedipine—Nitrendipine—ABCB1—esophageal cancer	0.000176	0.0728	CrCbGaD
Nifedipine—Myalgia—Cisplatin—esophageal cancer	0.000175	0.00223	CcSEcCtD
Nifedipine—Haemoglobin—Capecitabine—esophageal cancer	0.000175	0.00223	CcSEcCtD
Nifedipine—Rhinitis—Capecitabine—esophageal cancer	0.000174	0.00223	CcSEcCtD
Nifedipine—Anxiety—Cisplatin—esophageal cancer	0.000174	0.00222	CcSEcCtD
Nifedipine—Haemorrhage—Capecitabine—esophageal cancer	0.000174	0.00222	CcSEcCtD
Nifedipine—Hepatitis—Capecitabine—esophageal cancer	0.000174	0.00222	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000174	0.00222	CcSEcCtD
Nifedipine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000173	0.00221	CcSEcCtD
Nifedipine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000173	0.00221	CcSEcCtD
Nifedipine—Discomfort—Cisplatin—esophageal cancer	0.000173	0.00221	CcSEcCtD
Nifedipine—Pharyngitis—Capecitabine—esophageal cancer	0.000173	0.0022	CcSEcCtD
Nifedipine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000172	0.00219	CcSEcCtD
Nifedipine—Oedema peripheral—Capecitabine—esophageal cancer	0.000171	0.00219	CcSEcCtD
Nifedipine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000171	0.00218	CcSEcCtD
Nifedipine—Urethral disorder—Capecitabine—esophageal cancer	0.000171	0.00218	CcSEcCtD
Nifedipine—Breast disorder—Methotrexate—esophageal cancer	0.000169	0.00216	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000169	0.00215	CcSEcCtD
Nifedipine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000168	0.00214	CcSEcCtD
Nifedipine—Oedema—Cisplatin—esophageal cancer	0.000168	0.00214	CcSEcCtD
Nifedipine—Visual impairment—Capecitabine—esophageal cancer	0.000168	0.00214	CcSEcCtD
Nifedipine—ABCB1—trachea—esophageal cancer	0.000168	0.0065	CbGeAlD
Nifedipine—Erythema multiforme—Capecitabine—esophageal cancer	0.000165	0.0021	CcSEcCtD
Nifedipine—Nervous system disorder—Cisplatin—esophageal cancer	0.000164	0.0021	CcSEcCtD
Nifedipine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000164	0.00209	CcSEcCtD
Nifedipine—Tachycardia—Cisplatin—esophageal cancer	0.000164	0.00209	CcSEcCtD
Nifedipine—Skin disorder—Cisplatin—esophageal cancer	0.000163	0.00208	CcSEcCtD
Nifedipine—Eye disorder—Capecitabine—esophageal cancer	0.000163	0.00207	CcSEcCtD
Nifedipine—Tinnitus—Capecitabine—esophageal cancer	0.000162	0.00207	CcSEcCtD
Nifedipine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000162	0.00207	CcSEcCtD
Nifedipine—Flushing—Capecitabine—esophageal cancer	0.000162	0.00206	CcSEcCtD
Nifedipine—Cardiac disorder—Capecitabine—esophageal cancer	0.000162	0.00206	CcSEcCtD
Nifedipine—Eosinophilia—Methotrexate—esophageal cancer	0.00016	0.00204	CcSEcCtD
Nifedipine—Anorexia—Cisplatin—esophageal cancer	0.00016	0.00204	CcSEcCtD
Nifedipine—CYP1A1—lymph node—esophageal cancer	0.000159	0.00615	CbGeAlD
Nifedipine—Angiopathy—Capecitabine—esophageal cancer	0.000158	0.00201	CcSEcCtD
Nifedipine—Immune system disorder—Capecitabine—esophageal cancer	0.000157	0.00201	CcSEcCtD
Nifedipine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000157	0.002	CcSEcCtD
Nifedipine—Hypotension—Cisplatin—esophageal cancer	0.000157	0.002	CcSEcCtD
Nifedipine—Chills—Capecitabine—esophageal cancer	0.000156	0.00199	CcSEcCtD
Nifedipine—Arrhythmia—Capecitabine—esophageal cancer	0.000155	0.00198	CcSEcCtD
Nifedipine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000155	0.00198	CcSEcCtD
Nifedipine—Alopecia—Capecitabine—esophageal cancer	0.000154	0.00196	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000153	0.00195	CcSEcCtD
Nifedipine—Mental disorder—Capecitabine—esophageal cancer	0.000152	0.00194	CcSEcCtD
Nifedipine—Amlodipine—ABCB1—esophageal cancer	0.000152	0.0626	CrCbGaD
Nifedipine—Erythema—Capecitabine—esophageal cancer	0.000152	0.00193	CcSEcCtD
Nifedipine—Malnutrition—Capecitabine—esophageal cancer	0.000152	0.00193	CcSEcCtD
Nifedipine—Dysuria—Methotrexate—esophageal cancer	0.000151	0.00193	CcSEcCtD
Nifedipine—Paraesthesia—Cisplatin—esophageal cancer	0.000151	0.00192	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00015	0.00192	CcSEcCtD
Nifedipine—Dyspnoea—Cisplatin—esophageal cancer	0.00015	0.00191	CcSEcCtD
Nifedipine—Flatulence—Capecitabine—esophageal cancer	0.000149	0.0019	CcSEcCtD
Nifedipine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000149	0.0019	CcSEcCtD
Nifedipine—Dysgeusia—Capecitabine—esophageal cancer	0.000148	0.00189	CcSEcCtD
Nifedipine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000148	0.00188	CcSEcCtD
Nifedipine—Back pain—Capecitabine—esophageal cancer	0.000147	0.00187	CcSEcCtD
Nifedipine—Decreased appetite—Cisplatin—esophageal cancer	0.000146	0.00186	CcSEcCtD
Nifedipine—Muscle spasms—Capecitabine—esophageal cancer	0.000146	0.00186	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000145	0.00185	CcSEcCtD
Nifedipine—ABCB1—digestive system—esophageal cancer	0.000144	0.00559	CbGeAlD
Nifedipine—Pain—Cisplatin—esophageal cancer	0.000143	0.00183	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000143	0.00183	CcSEcCtD
Nifedipine—Vision blurred—Capecitabine—esophageal cancer	0.000143	0.00182	CcSEcCtD
Nifedipine—Tremor—Capecitabine—esophageal cancer	0.000142	0.00181	CcSEcCtD
Nifedipine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000141	0.00179	CcSEcCtD
Nifedipine—Conjunctivitis—Methotrexate—esophageal cancer	0.00014	0.00179	CcSEcCtD
Nifedipine—Felodipine—ABCB1—esophageal cancer	0.00014	0.0579	CrCbGaD
Nifedipine—Anaemia—Capecitabine—esophageal cancer	0.00014	0.00179	CcSEcCtD
Nifedipine—Sweating—Methotrexate—esophageal cancer	0.000138	0.00176	CcSEcCtD
Nifedipine—Feeling abnormal—Cisplatin—esophageal cancer	0.000138	0.00176	CcSEcCtD
Nifedipine—Haematuria—Methotrexate—esophageal cancer	0.000138	0.00176	CcSEcCtD
Nifedipine—Malaise—Capecitabine—esophageal cancer	0.000137	0.00174	CcSEcCtD
Nifedipine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000136	0.00174	CcSEcCtD
Nifedipine—Epistaxis—Methotrexate—esophageal cancer	0.000136	0.00174	CcSEcCtD
Nifedipine—Vertigo—Capecitabine—esophageal cancer	0.000136	0.00174	CcSEcCtD
Nifedipine—Syncope—Capecitabine—esophageal cancer	0.000136	0.00173	CcSEcCtD
Nifedipine—Leukopenia—Capecitabine—esophageal cancer	0.000136	0.00173	CcSEcCtD
Nifedipine—Agranulocytosis—Methotrexate—esophageal cancer	0.000135	0.00172	CcSEcCtD
Nifedipine—Palpitations—Capecitabine—esophageal cancer	0.000134	0.00171	CcSEcCtD
Nifedipine—Nicardipine—ABCB1—esophageal cancer	0.000133	0.0551	CrCbGaD
Nifedipine—Loss of consciousness—Capecitabine—esophageal cancer	0.000133	0.0017	CcSEcCtD
Nifedipine—Body temperature increased—Cisplatin—esophageal cancer	0.000133	0.00169	CcSEcCtD
Nifedipine—Cough—Capecitabine—esophageal cancer	0.000132	0.00169	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—esophageal cancer	0.00013	0.00166	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—esophageal cancer	0.00013	0.00165	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—esophageal cancer	0.00013	0.00165	CcSEcCtD
Nifedipine—Arthralgia—Capecitabine—esophageal cancer	0.000129	0.00165	CcSEcCtD
Nifedipine—Chest pain—Capecitabine—esophageal cancer	0.000129	0.00165	CcSEcCtD
Nifedipine—Myalgia—Capecitabine—esophageal cancer	0.000129	0.00165	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—esophageal cancer	0.000129	0.00164	CcSEcCtD
Nifedipine—Anxiety—Capecitabine—esophageal cancer	0.000129	0.00164	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000128	0.00163	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000128	0.00163	CcSEcCtD
Nifedipine—Discomfort—Capecitabine—esophageal cancer	0.000127	0.00163	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—esophageal cancer	0.000127	0.00162	CcSEcCtD
Nifedipine—Dry mouth—Capecitabine—esophageal cancer	0.000126	0.00161	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—esophageal cancer	0.000125	0.00159	CcSEcCtD
Nifedipine—Confusional state—Capecitabine—esophageal cancer	0.000125	0.00159	CcSEcCtD
Nifedipine—Oedema—Capecitabine—esophageal cancer	0.000124	0.00158	CcSEcCtD
Nifedipine—Hypersensitivity—Cisplatin—esophageal cancer	0.000124	0.00158	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—esophageal cancer	0.000122	0.00156	CcSEcCtD
Nifedipine—Shock—Capecitabine—esophageal cancer	0.000122	0.00155	CcSEcCtD
Nifedipine—Nervous system disorder—Capecitabine—esophageal cancer	0.000121	0.00155	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—esophageal cancer	0.000121	0.00154	CcSEcCtD
Nifedipine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000121	0.00154	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—esophageal cancer	0.000121	0.00154	CcSEcCtD
Nifedipine—Tachycardia—Capecitabine—esophageal cancer	0.000121	0.00154	CcSEcCtD
Nifedipine—ABCB1—lung—esophageal cancer	0.00012	0.00467	CbGeAlD
Nifedipine—Asthenia—Cisplatin—esophageal cancer	0.00012	0.00154	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—esophageal cancer	0.00012	0.00153	CcSEcCtD
Nifedipine—Skin disorder—Capecitabine—esophageal cancer	0.00012	0.00153	CcSEcCtD
Nifedipine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00012	0.00152	CcSEcCtD
Nifedipine—Anorexia—Capecitabine—esophageal cancer	0.000118	0.0015	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—esophageal cancer	0.000118	0.0015	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—esophageal cancer	0.000117	0.00149	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000117	0.00149	CcSEcCtD
Nifedipine—Chills—Methotrexate—esophageal cancer	0.000116	0.00148	CcSEcCtD
Nifedipine—Hypotension—Capecitabine—esophageal cancer	0.000116	0.00147	CcSEcCtD
Nifedipine—Diarrhoea—Cisplatin—esophageal cancer	0.000115	0.00146	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—esophageal cancer	0.000114	0.00146	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—esophageal cancer	0.000114	0.00145	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—esophageal cancer	0.000113	0.00144	CcSEcCtD
Nifedipine—Erythema—Methotrexate—esophageal cancer	0.000113	0.00144	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000113	0.00144	CcSEcCtD
Nifedipine—Insomnia—Capecitabine—esophageal cancer	0.000112	0.00143	CcSEcCtD
Nifedipine—Paraesthesia—Capecitabine—esophageal cancer	0.000111	0.00142	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—esophageal cancer	0.00011	0.00141	CcSEcCtD
Nifedipine—Dyspnoea—Capecitabine—esophageal cancer	0.00011	0.00141	CcSEcCtD
Nifedipine—Back pain—Methotrexate—esophageal cancer	0.000109	0.00139	CcSEcCtD
Nifedipine—Dyspepsia—Capecitabine—esophageal cancer	0.000109	0.00139	CcSEcCtD
Nifedipine—Decreased appetite—Capecitabine—esophageal cancer	0.000107	0.00137	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000107	0.00136	CcSEcCtD
Nifedipine—Vomiting—Cisplatin—esophageal cancer	0.000107	0.00136	CcSEcCtD
Nifedipine—Fatigue—Capecitabine—esophageal cancer	0.000107	0.00136	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—esophageal cancer	0.000106	0.00136	CcSEcCtD
Nifedipine—Rash—Cisplatin—esophageal cancer	0.000106	0.00135	CcSEcCtD
Nifedipine—Constipation—Capecitabine—esophageal cancer	0.000106	0.00135	CcSEcCtD
Nifedipine—Pain—Capecitabine—esophageal cancer	0.000106	0.00135	CcSEcCtD
Nifedipine—Dermatitis—Cisplatin—esophageal cancer	0.000106	0.00135	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000105	0.00133	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—esophageal cancer	0.000104	0.00133	CcSEcCtD
Nifedipine—Feeling abnormal—Capecitabine—esophageal cancer	0.000102	0.0013	CcSEcCtD
Nifedipine—Malaise—Methotrexate—esophageal cancer	0.000102	0.0013	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—esophageal cancer	0.000101	0.00129	CcSEcCtD
Nifedipine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000101	0.00129	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—esophageal cancer	0.000101	0.00129	CcSEcCtD
Nifedipine—Nausea—Cisplatin—esophageal cancer	9.96e-05	0.00127	CcSEcCtD
Nifedipine—Cough—Methotrexate—esophageal cancer	9.84e-05	0.00126	CcSEcCtD
Nifedipine—Urticaria—Capecitabine—esophageal cancer	9.82e-05	0.00125	CcSEcCtD
Nifedipine—Abdominal pain—Capecitabine—esophageal cancer	9.77e-05	0.00125	CcSEcCtD
Nifedipine—Body temperature increased—Capecitabine—esophageal cancer	9.77e-05	0.00125	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—esophageal cancer	9.6e-05	0.00122	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—esophageal cancer	9.6e-05	0.00122	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—esophageal cancer	9.6e-05	0.00122	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	9.54e-05	0.00122	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—esophageal cancer	9.49e-05	0.00121	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—esophageal cancer	9.28e-05	0.00118	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—esophageal cancer	9.2e-05	0.00117	CcSEcCtD
Nifedipine—Hypersensitivity—Capecitabine—esophageal cancer	9.11e-05	0.00116	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—esophageal cancer	9.03e-05	0.00115	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—esophageal cancer	9.01e-05	0.00115	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—esophageal cancer	8.94e-05	0.00114	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—esophageal cancer	8.9e-05	0.00113	CcSEcCtD
Nifedipine—Asthenia—Capecitabine—esophageal cancer	8.87e-05	0.00113	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—esophageal cancer	8.77e-05	0.00112	CcSEcCtD
Nifedipine—Pruritus—Capecitabine—esophageal cancer	8.75e-05	0.00112	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—esophageal cancer	8.6e-05	0.0011	CcSEcCtD
Nifedipine—Diarrhoea—Capecitabine—esophageal cancer	8.46e-05	0.00108	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.39e-05	0.00107	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—esophageal cancer	8.33e-05	0.00106	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—esophageal cancer	8.27e-05	0.00105	CcSEcCtD
Nifedipine—ABCB1—lymph node—esophageal cancer	8.24e-05	0.00319	CbGeAlD
Nifedipine—Dyspnoea—Methotrexate—esophageal cancer	8.21e-05	0.00105	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—esophageal cancer	8.18e-05	0.00104	CcSEcCtD
Nifedipine—Dizziness—Capecitabine—esophageal cancer	8.18e-05	0.00104	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—esophageal cancer	8.1e-05	0.00103	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—esophageal cancer	8e-05	0.00102	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—esophageal cancer	7.95e-05	0.00101	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—esophageal cancer	7.94e-05	0.00101	CcSEcCtD
Nifedipine—Pain—Methotrexate—esophageal cancer	7.87e-05	0.001	CcSEcCtD
Nifedipine—Vomiting—Capecitabine—esophageal cancer	7.86e-05	0.001	CcSEcCtD
Nifedipine—Rash—Capecitabine—esophageal cancer	7.8e-05	0.000994	CcSEcCtD
Nifedipine—Dermatitis—Capecitabine—esophageal cancer	7.79e-05	0.000993	CcSEcCtD
Nifedipine—Headache—Capecitabine—esophageal cancer	7.75e-05	0.000988	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—esophageal cancer	7.59e-05	0.000967	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—esophageal cancer	7.53e-05	0.00096	CcSEcCtD
Nifedipine—Nausea—Capecitabine—esophageal cancer	7.34e-05	0.000937	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—esophageal cancer	7.31e-05	0.000933	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—esophageal cancer	7.28e-05	0.000928	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—esophageal cancer	7.28e-05	0.000928	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—esophageal cancer	6.78e-05	0.000865	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—esophageal cancer	6.6e-05	0.000842	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—esophageal cancer	6.51e-05	0.000831	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—esophageal cancer	6.3e-05	0.000803	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—esophageal cancer	6.09e-05	0.000776	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—esophageal cancer	5.85e-05	0.000746	CcSEcCtD
Nifedipine—Rash—Methotrexate—esophageal cancer	5.8e-05	0.00074	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—esophageal cancer	5.8e-05	0.00074	CcSEcCtD
Nifedipine—Headache—Methotrexate—esophageal cancer	5.77e-05	0.000736	CcSEcCtD
Nifedipine—Nausea—Methotrexate—esophageal cancer	5.47e-05	0.000697	CcSEcCtD
Nifedipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.88e-06	3.03e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	3.85e-06	3.01e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.83e-06	3e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—HMOX1—esophageal cancer	3.83e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.76e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NOS2—esophageal cancer	3.75e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFBR2—esophageal cancer	3.73e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NOTCH1—esophageal cancer	3.72e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.72e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.67e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ABCB1—esophageal cancer	3.67e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	3.67e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CASP8—esophageal cancer	3.67e-06	2.87e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.66e-06	2.86e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.65e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CREBBP—esophageal cancer	3.65e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ENO1—esophageal cancer	3.65e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS1—esophageal cancer	3.65e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—EGFR—esophageal cancer	3.64e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	3.63e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NOS2—esophageal cancer	3.63e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NOS2—esophageal cancer	3.63e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFBR2—esophageal cancer	3.61e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFBR2—esophageal cancer	3.61e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NOTCH1—esophageal cancer	3.6e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NOTCH1—esophageal cancer	3.6e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PSME2—esophageal cancer	3.6e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PSME1—esophageal cancer	3.6e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—CREBBP—esophageal cancer	3.59e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.58e-06	2.8e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CASP8—esophageal cancer	3.55e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CASP8—esophageal cancer	3.55e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.55e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SMAD4—esophageal cancer	3.53e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CREBBP—esophageal cancer	3.53e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CREBBP—esophageal cancer	3.53e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—EGFR—esophageal cancer	3.52e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—EGFR—esophageal cancer	3.52e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—NOS3—esophageal cancer	3.51e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—PIK3CA—esophageal cancer	3.51e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—EGFR—esophageal cancer	3.49e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.44e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SMAD4—esophageal cancer	3.42e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SMAD4—esophageal cancer	3.42e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.41e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—esophageal cancer	3.39e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—PIK3CA—esophageal cancer	3.39e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—PIK3CA—esophageal cancer	3.39e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—EGFR—esophageal cancer	3.38e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—EGFR—esophageal cancer	3.38e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GNG7—esophageal cancer	3.37e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CREBBP—esophageal cancer	3.37e-06	2.63e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—HMOX1—esophageal cancer	3.33e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—esophageal cancer	3.28e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—esophageal cancer	3.28e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CREBBP—esophageal cancer	3.26e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CREBBP—esophageal cancer	3.26e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	3.23e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—NOS3—esophageal cancer	3.22e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTGS2—esophageal cancer	3.21e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.16e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—PIK3CA—esophageal cancer	3.16e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—BCL2—esophageal cancer	3.15e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.14e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.14e-06	2.45e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.12e-06	2.43e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.1e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ERBB2—esophageal cancer	3.06e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.06e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—PIK3CA—esophageal cancer	3.05e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—PIK3CA—esophageal cancer	3.05e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—BCL2—esophageal cancer	3.04e-06	2.38e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—BCL2—esophageal cancer	3.04e-06	2.38e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—PIK3CA—esophageal cancer	3.03e-06	2.37e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.03e-06	2.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NOS3—esophageal cancer	3.02e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.02e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.01e-06	2.35e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.99e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.97e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ERBB2—esophageal cancer	2.96e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ERBB2—esophageal cancer	2.96e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—esophageal cancer	2.94e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—PIK3CA—esophageal cancer	2.93e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—PIK3CA—esophageal cancer	2.93e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NOS3—esophageal cancer	2.92e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NOS3—esophageal cancer	2.92e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.92e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—CREBBP—esophageal cancer	2.9e-06	2.27e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PIK3CA—esophageal cancer	2.89e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HIF1A—esophageal cancer	2.89e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—CREBBP—esophageal cancer	2.84e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.83e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—CREBBP—esophageal cancer	2.82e-06	2.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—ERBB2—esophageal cancer	2.82e-06	2.21e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ENO1—esophageal cancer	2.82e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.82e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HIF1A—esophageal cancer	2.8e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HIF1A—esophageal cancer	2.8e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.78e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PSME1—esophageal cancer	2.78e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PSME2—esophageal cancer	2.78e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KDR—esophageal cancer	2.76e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—esophageal cancer	2.76e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—CREBBP—esophageal cancer	2.73e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—CREBBP—esophageal cancer	2.73e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—ERBB2—esophageal cancer	2.73e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—ERBB2—esophageal cancer	2.73e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—CREBBP—esophageal cancer	2.68e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KDR—esophageal cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KDR—esophageal cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—EP300—esophageal cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—esophageal cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—esophageal cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.66e-06	2.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CDKN1A—esophageal cancer	2.61e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.61e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	2.6e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—NOS3—esophageal cancer	2.6e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.56e-06	2e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—NOS3—esophageal cancer	2.54e-06	1.99e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—NOS3—esophageal cancer	2.54e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CDKN1A—esophageal cancer	2.53e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CDKN1A—esophageal cancer	2.53e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—NOS3—esophageal cancer	2.53e-06	1.97e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	2.52e-06	1.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	2.52e-06	1.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EP300—esophageal cancer	2.49e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—CREBBP—esophageal cancer	2.46e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—EP300—esophageal cancer	2.45e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—NOS3—esophageal cancer	2.44e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—NOS3—esophageal cancer	2.44e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CDKN1A—esophageal cancer	2.41e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EP300—esophageal cancer	2.41e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EP300—esophageal cancer	2.41e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—NOS3—esophageal cancer	2.4e-06	1.87e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.39e-06	1.87e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.38e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CREBBP—esophageal cancer	2.36e-06	1.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1A—esophageal cancer	2.33e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1A—esophageal cancer	2.33e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—esophageal cancer	2.33e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.32e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—esophageal cancer	2.32e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—esophageal cancer	2.31e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EP300—esophageal cancer	2.3e-06	1.79e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CREBBP—esophageal cancer	2.28e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CREBBP—esophageal cancer	2.28e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.26e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.25e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—esophageal cancer	2.24e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—esophageal cancer	2.24e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—esophageal cancer	2.24e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—esophageal cancer	2.24e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EP300—esophageal cancer	2.22e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EP300—esophageal cancer	2.22e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—NOS3—esophageal cancer	2.2e-06	1.72e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—esophageal cancer	2.19e-06	1.71e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CREBBP—esophageal cancer	2.14e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—esophageal cancer	2.12e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—esophageal cancer	2.11e-06	1.65e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.05e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—esophageal cancer	2.05e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—esophageal cancer	2.05e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—esophageal cancer	2.04e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—esophageal cancer	2.04e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.02e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	2.01e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.01e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—esophageal cancer	2e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CREBBP—esophageal cancer	2e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—esophageal cancer	1.98e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.98e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—esophageal cancer	1.98e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.97e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—esophageal cancer	1.96e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	1.95e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.95e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—esophageal cancer	1.93e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—esophageal cancer	1.93e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—esophageal cancer	1.93e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.93e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—esophageal cancer	1.93e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—esophageal cancer	1.92e-06	1.5e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—esophageal cancer	1.92e-06	1.5e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—esophageal cancer	1.91e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—esophageal cancer	1.91e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—esophageal cancer	1.89e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—esophageal cancer	1.89e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—esophageal cancer	1.86e-06	1.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—esophageal cancer	1.86e-06	1.45e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—esophageal cancer	1.84e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—esophageal cancer	1.82e-06	1.43e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	1.81e-06	1.42e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.8e-06	1.41e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.79e-06	1.4e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—esophageal cancer	1.78e-06	1.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—esophageal cancer	1.78e-06	1.39e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.75e-06	1.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—esophageal cancer	1.75e-06	1.36e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.71e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—esophageal cancer	1.7e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	1.69e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—esophageal cancer	1.69e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—esophageal cancer	1.69e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—esophageal cancer	1.67e-06	1.31e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.65e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—esophageal cancer	1.64e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—esophageal cancer	1.64e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.64e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	1.63e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	1.63e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—esophageal cancer	1.61e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—esophageal cancer	1.55e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—esophageal cancer	1.55e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.53e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.46e-06	1.14e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—esophageal cancer	1.46e-06	1.14e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.43e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.43e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—esophageal cancer	1.42e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—esophageal cancer	1.4e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.4e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—esophageal cancer	1.38e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—esophageal cancer	1.38e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—esophageal cancer	1.37e-06	1.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—esophageal cancer	1.37e-06	1.07e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—esophageal cancer	1.36e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—esophageal cancer	1.36e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—esophageal cancer	1.36e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	1.35e-06	1.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—esophageal cancer	1.33e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—esophageal cancer	1.33e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.32e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.24e-06	9.67e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	1.19e-06	9.29e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.18e-06	9.22e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—esophageal cancer	1.16e-06	9.09e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—esophageal cancer	1.15e-06	8.99e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	1.15e-06	8.99e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	1.15e-06	8.99e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—esophageal cancer	1.11e-06	8.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—esophageal cancer	1.11e-06	8.7e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.08e-06	8.43e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.08e-06	8.42e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.02e-06	7.94e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.01e-06	7.87e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—esophageal cancer	8.98e-07	7.01e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	8.6e-07	6.72e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.64e-07	5.19e-06	CbGpPWpGaD
